Ensysce Biosciences (ENSC) vs Jaguar Health (JAGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Ensysce Biosciences is the larger company by market cap ($8.9 million vs $8.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ENSC | JAGX |
|---|---|---|
| Share price | $0.458 | $4.53 |
| Market cap | $8.91M | $8.81M |
| 1-day change | +6.66% | -9.40% |
| EPS (TTM) | $-2.47 | $-4,012.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.75 | $1,267.88 |
| 52-week low | $0.23 | $2.35 |
| Distance from 52-week high | -83.35% | -99.64% |
| Average volume | 14.19M | 2.00M |
| Shares outstanding | 19.46M | 1.95M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ENSC vs JAGX FAQ
Which is bigger, Ensysce Biosciences or Jaguar Health?
Ensysce Biosciences (ENSC) is larger, with a market capitalization of $8.91M compared with $8.81M for Jaguar Health (JAGX).
Are Ensysce Biosciences and Jaguar Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.